Abstract Overview: Validation of Natural Language Processing (NLP) of EGFR and ALK Tests in NSCLC Patients - 102164

Spotlight
Video

Abstract Overview: Validation of Natural Language Processing (NLP) of EGFR and ALK Tests in NSCLC Patients

Loading........
Description: Bernardo H. Goulart, MD, MS of Seattle Cancer Care Alliance discusses the use of natural language processing (NLP) for patients with non-small cell lung cancer. This was recorded at the 2017 ASCO Annual Meeting in Chicago, IL.

Abstract 6528: Validation of natural language processing (NLP) for automated ascertainment of EGFR and ALK tests in SEER cases of non-small cell lung cancer (NSCLC).
Shared By : AnnualMeeting2017
Posted on : 06/05/17
Added : 9 months ago



Recommended

Nothing found.

More From AnnualMeeting2017

Nothing found.